Navigation Links
NIAID awards contracts to search for protein markers of disease
Date:10/9/2008

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two five-year contracts to establish Clinical Proteomics Centers for Infectious Diseases and Biodefense. The contracts were awarded to the University of Texas Medical Branch (UTMB), Galveston, and to the Canadian firm Caprion Proteomics, Montreal. Researchers at the centers will analyze human blood and other tissue samples from completed or ongoing clinical studies with the aim of discovering proteins that could serve as biomarkers of infectious disease.

A biomarker is a measurable biological substance that acts as an indicator of either health or disease. One biomarker test now used by doctors is the prostate-specific antigen (PSA) blood test for prostate cancer screening. Elevated levels of PSA protein in the blood may signal the presence of cancerous cells in the prostate gland.

Scientists at the new NIAID-funded centers will look for proteins produced either by disease-causing agents or by the immune system in response to infection. "Identifying specific biomarkers that are present in infected people--but absent in uninfected people--would give researchers new leads in understanding how microbes cause disease and how the body reacts to those microbes," says Maureen Beanan, Ph.D., a program officer in NIAID's Division of Microbiology and Infectious Diseases. This, in turn, could guide development of diagnostics, therapies or vaccines, she adds.

The first two diseases to be studied at the new centers will be dengue fever, a viral illness spread by mosquitoes, and brucellosis, a bacterial disease that can cause severe influenza-like symptoms. Once discovered and characterized, any candidate biomarkers found by the centers' scientists will be made freely available to the research community at large for further development.

The centers also will encourage clinical infectious disease researchers from other institutions to submit clinical samples to be assessed for the presence of potential biomarker proteins, notes Dr. Beanan. This service will be provided at no charge to the requestors.

The five-year contract to UTMB is estimated to be up to $10.9 million. The five-year contract to Caprion Proteomics is estimated to be up to $12.9 million.

Besides the new clinical proteomics centers, NIAID has established numerous research resources in the areas of bioinformatics, functional and structural genomics, and gene and protein sequencing. Together, these resources are assisting scientists to better understand interactions between disease-causing organisms and the human immune response. For more information about these resources, see http://www3.niaid.nih.gov/topics/pathogenGenomics.


'/>"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related medicine news :

1. NIAID funds $51M contract to create comprehensive model of immune responses
2. NIAID strengthens and expands Vaccine and Treatment Evaluation Units
3. NIAID scientists identify new cellular receptor for HIV
4. NIAID to convene HIV Vaccine Summit
5. NIAID describes research priorities to fight drug-resistant tuberculosis
6. NIAID to advance B-cell approach to HIV vaccines
7. NIAID creates HIV vaccine discovery branch
8. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
9. Good Clinical Practice Journal Awards: Winners Announced
10. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities ... within the industry, from leading advocates, associations and industry leaders such as Bioness. ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... which come courtesy of leaders in the nursing and health care industry. It also ... and associations—namely Abilene Christian University. , As the nursing industry is coming out ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to ... Sausage Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of ... grilling is their favorite way to cook a hot dog, far outpacing other cooking ...
(Date:5/26/2016)... Georgia (PRWEB) , ... May 26, 2016 , ... ... certificate in intellectual property (IP) to its specialty academic programs. , Answering to ... the college’s existing certificate programs in health law, and environmental and land use ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is a ... on long-term patient survival, reports a team of UPMC researchers in the largest ... the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will hopefully ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... PARIS , May 25, 2016 ... system disorders, announces that an oral presentation entitled "High doses ... the MS-SPI trial" will be given by Professor Ayman ... the 2nd Congress of the European Academy of Neurology (EAN) ... "MS and related disorders 3" will take place on Sunday, ...
(Date:5/24/2016)... , May 24, 2016 ... den Markt gebracht, die es Ärzten erlaubt, ihre ... zu behandeln: MDLinking kombiniert Live Streaming mit einer ... Umfeld zu kommunizieren. Mediziner in Europa, Afrika, Asien ... sich bereits für die Plattform registriert. ...
Breaking Medicine Technology: